Aetna stops paing Bextra claims.

NEW YORK, April 11 (Reuters) - Health insurer Aetna Inc. (AET) said on Monday it is not paying any claims for Bextra, a pain reliever that the FDA requested to be removed from the market, for prescriptions as of April 7.

The Hartford-based company said it is contacting more than 33,000 customers who have used Bextra to inform them of the U.S. Food and Drug Administration's (FDA) decision to ask that Bextra be withdrawn from the market.

Read more